Clinical Trial Update: Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for clonidine HCl MBT vs placebo to prevent chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer; study status is termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemoradiotherapy-induced Oral Mucositis
• Oropharyngeal Cancer

Drugs mentioned

• Clonidine HCl MBT (clonidine)

Snippet

Sponsor: Monopar Therapeutics | Conditions: Chemoradiotherapy-Induced Severe Oral Mucositis | Phase 2, Phase 3 | Status: TERMINATED